Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Cadm3 (Necl-1) interferes with the activation of the PI3 kinase/Akt signaling cascade and inhibits Schwann cell myelination in vitro.
Poster 224 Giant Cell Myocarditis Masked by Acute Inflammatory Demyelinating Polyneuropathy: A Case Report.
Accelerated remyelination during inflammatory demyelination prevents axonal loss and improves functional recovery.
Imag(in)ing multiple sclerosis: Time to take better pictures.
Acute Disseminated Encephalomyelitis Following Immunization with Human Papillomavirus Vaccines.
NMDA receptor antibodies: A rare association in inflammatory demyelinating diseases.
Enhancement of aptamer immobilization using egg shell-derived nano-sized spherical hydroxyapatite for thrombin detection in neuroclinic.
Time- and Region-Specific Season of Birth Effects in Multiple Sclerosis in the United Kingdom.
Malignant chondroid syringoma in a West African cancer institute: A case report.
Serum BAFF levels, Methypredsinolone therapy, Epstein-Barr Virus and Mycobacterium avium subsp. paratuberculosis infection in Multiple Sclerosis patients.
Neuroprotective effect of nitric oxide donor isosorbide-dinitrate against oxidative stress induced by ethidium bromide in rat brain.
DNA damage in the oligodendrocyte lineage and its role in brain aging.
Relationship between the corpus callosum and neurocognitive disabilities in children with NF-1: diffusion tensor imaging features.
The Influence of Differentially Expressed Tissue-Type Plasminogen Activator in Experimental Autoimmune Encephalomyelitis: Implications for Multiple Sclerosis.
Journal Club: Effect of comorbidity on mortality in multiple sclerosis.
Ongoing increase in incidence and prevalence of multiple sclerosis in Newcastle, Australia: A 50-year study.
Two novel variants in CNTNAP1 in two siblings presenting with congenital hypotonia and hypomyelinating neuropathy.
Defects in the COG complex and COG-related trafficking regulators affect neuronal Golgi function.
Exploring the Implications of Small-Area Variation in the Incidence of Multiple Sclerosis.
Nuclear factor erythroid 2-related factor 2 is a critical target for the treatment of glucocorticoid-resistant lupus nephritis.
Determinants of non-adherence to disease-modifying therapies in multiple sclerosis: A cross-Canada prospective study.
Is it worth to report the presence of a single and additional band in the cerebrospinal fluid detected by isoelectrofocusing?
Global gene expression profiles in brain regions reflecting abnormal neuronal and glial functions targeting myelin sheaths after 28-day exposure to cuprizone in rats.
Naphthoquinoxaline metabolite of mitoxantrone is less cardiotoxic than the parent compound and it can be a more cardiosafe drug in anticancer therapy.
Selected CSF biomarkers indicate no evidence of early neuroinflammation in Huntington disease.
Pages
« first
‹ previous
…
834
835
836
837
838
839
840
841
842
…
next ›
last »